A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
Dr. Joanne Liu, an N.Y.U. graduate, said the cancellation of her presentation on humanitarian crises was a sign of the ...
The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...
NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...
The school district became aware of the fraud — which had been perpetrated for five years — and reported it to the Suffolk ...
A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted ...
NYU Langone Health on Monday named Dr. Alec Kimmelman as its next CEO and dean of New York University's Grossman School of Medicine. Kimmelman, who has been leading NYU Langone's Laura and Isaac ...
The American Academy of Dermatology has announced the results of its annual election. The Academy’s new officers and board members will lead the world’s largest dermatologic society, representing more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback